🕵️ Iterum Therapeutics PLC ($ITRMF)
SEC insider & ownership activity, last 12 months · CIK 1659323 · every row links its SEC filing
Over the last 12 months insiders bought $2K with no open-market selling against it. Michael W. Dunne bought $2K in discretionary trades (Nov). 5 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Mar 30, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $2K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Michael W. Dunne | 1 | $2K | 0 | – | Nov 18, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Bankruptcy (1.03) | Mar 27, 2026 | filing ↗ |
| Debt acceleration (2.04) | Mar 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Other events (8.01) | Mar 3, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 18, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Delisting notice (3.01) | Dec 11, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Other events (8.01) | Oct 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 16, 2025 | filing ↗ |